open access

https://hdl.handle.net/2115/62921

Prospective risk of stillbirth in women with placental mesenchymal dysplasia

英語

prophylactic treatment

2015-10

Wiley-Blackwell

Journal of obstetrics and gynaecology research

41(10)

1562-1568

Aim: The aim of this study was to provide better counsel to pregnant women with suspected placental mesenchymal dysplasia (PMD) regarding the risks of preterm birth and intrauterine fetal death. Material and Methods: We reviewed the outcomes of 109 PMD pregnancies with gestational week (GW) ≥ 24 abstracted from 63 reports in the English-language published reports, including two cases that we encountered recently. The prospective risk of stillbirth at GW N was defined as the number of women with stillbirth at GW ≥ N divided by the number of women giving birth at GW ≥ N. Results: A total of 32 (29.4%) women experienced stillbirth at a median GW of 31 (range, 24-38). Preterm birth (GW < 37) occurred in 52 (67.5%) of the 77 live-born infants. Only 25 (22.9%) women had full-term (GW ≥ 37) live-born infants. The prospective risks of stillbirth were 29.4% (32/109), 27.5% (25/91), 20.9% (14/67) and 13.0% (6/46) for women who reached GW 24(+0), 28(+0), 32(+0) and 36(+0) respectively. Conclusion: As women with PMD are at markedly elevated risk of intrauterine fetal death, early admission to the hospital and intensive monitoring of fetal status should be considered, although whether this policy improves outcome has not been validated.

学術雑誌論文

Accepted Manuscript

This is the peer reviewed version of the following article: Ishikawa, S., Morikawa, M., Yamada, T., Akaishi, R., Kaneuchi, M., and Minakami, H. (2015) Prospective risk of stillbirth in women with placental mesenchymal dysplasia. J. Obstet. Gynaecol. Res., 41: 1562–1568., which has been published in final form at http://dx.doi.org/10.1111/jog.12757. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.

1341-8076